Kinase, in vitro: 

An enzyme-substrate reaction that occurs in non-living experimental conditions such as a test tube. For example, a purified enzyme is reacted with a substrate protein or mixture of proteins or peptides.

mTOR S766-p , S774-p
 Putative in vivo kinases: 

An enzyme-substrate reaction that occurs within living cells; includes cultured cells, ex vivo samples, and intact organisms. In the case of kinases, the large number of protein kinases in intact cells makes exact identification of the responsible kinase challenging.

CDK2 T303-p , T649-p , S774-p
Regulatory protein:
OGT S774-p
PRP4 T769-p , Y777-p , S1040-p
Treatment:
angiotensin_2 S766-p , S774-p , Y777-p
anti-CD3 S774-p
BI_4834 S824-p
dasatinib S90-p , S143-p , S517-p , S548-p , S774-p
EGF S143-p , T649-p , S774-p , T788-p , S824-p
gefitinib S847-p , S850-p , S851-p
imatinib T845-p , S847-p , S849-p , S850-p , S851-p , S853-p , T856-p , T858-p
ischemia S165-p , T376-p , S517-p , S584-p , S774-p , S824-p , S1089-p
LRRK2-IN-1 S90-p , T376-p , S766-p , S774-p , S824-p
metastatic potential S1040-p
MG132 S217-p , K539-ub , K753-ub
MG132_withdrawal S217-p
nocodazole S143-p , S215-p , S220-p , T376-p , S548-p , T649-p , S766-p , S774-p
quinalizarin S548-p
rapamycin T845-p , S847-p , S849-p , S850-p , S851-p , S853-p , T856-p , T858-p , S861-p , T865-p
selumetinib T376-p
SII_angiotensin_2 S90-p , S165-p
Su11274 S824-p , T845-p , S847-p , S849-p , S850-p , S851-p , T856-p , S1056-p
Torin1 S766-p , T769-p , S774-p , S847-p , S849-p
U0126 S847-p , S849-p , S850-p , T856-p , S861-p
vemurafenib T376-p
wortmannin S824-p , T845-p , S847-p , S850-p , S851-p , T856-p , S1056-p
Y27632 S774-p , S823-p